Positive CHMP Opinion for DLBCL

AbbVie’s Epcoritamab Gets CHMP Nod for DLBCL

AbbVie’s Epcoritamab (EPKINLY) Receives Positive CHMP Opinion for DLBCL Treatment

SG Tylor

Source – AbbVieAbbVie and Genmab’s potential blockbuster drug epcoritamab has received a favorable recommendation for conditional approval in the EU ...